Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder

An inside perspective on how long-term alignment, operational clarity, and steady visibility influence strategic interest—and what makes a company attractive well before any deal takes shape.

A view into the financial pathways of hardtech growth, where milestones, readiness, and capital strategy work together to move a product from early validation to sustainable scale.

A look at the decisions that shape resilient production. What to keep close, what to outsource, and how thoughtful design and strong partnerships drive consistency at scale.